A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.

Kerem Parlar, Eda Tahir Turanli, Eda Nuhoglu Kantarci, Aysa Hacioglu, Asli Kirectepe Aydin, Ali Yagiz Ayla, Umut Voyvoda, Huri Ozdogan, Serdal Ugurlu
{"title":"A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.","authors":"Kerem Parlar, Eda Tahir Turanli, Eda Nuhoglu Kantarci, Aysa Hacioglu, Asli Kirectepe Aydin, Ali Yagiz Ayla, Umut Voyvoda, Huri Ozdogan, Serdal Ugurlu","doi":"10.1093/mrcr/rxad045","DOIUrl":null,"url":null,"abstract":"<p><p>Deficiency of adenosine deaminase 2 (DADA2), caused by recessive mutations in the adenosine deaminase 2 (ADA2) gene, results in cutaneous or systemic vasculitis with variable clinical manifestations. There is only one other case in literature carrying both ADA2 and MEFV gene pathogenic variants. Here we report the second case that carries both ADA2 and MEFV pathogenic variants, presenting with characteristic phenotypes of both familial Mediterranean fever (FMF) and DADA2. A male patient, currently 29 years old, was initially diagnosed with FMF and developed livedo reticularis and nodular dermal lesions compatible with cutaneous polyarteritis nodosa (PAN) a year after diagnosis. His family history revealed a brother 2 years older than himself who was diagnosed with PAN and died at age 22 because of gut perforation secondary to acute mesenteric ischaemia. ADA2 gene mutation analysis on chromosome 22q11.1 was positive, and the patient responded to colchicine and infliximab.</p>","PeriodicalId":18677,"journal":{"name":"Modern Rheumatology Case Reports","volume":" ","pages":"121-124"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Rheumatology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/mrcr/rxad045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Deficiency of adenosine deaminase 2 (DADA2), caused by recessive mutations in the adenosine deaminase 2 (ADA2) gene, results in cutaneous or systemic vasculitis with variable clinical manifestations. There is only one other case in literature carrying both ADA2 and MEFV gene pathogenic variants. Here we report the second case that carries both ADA2 and MEFV pathogenic variants, presenting with characteristic phenotypes of both familial Mediterranean fever (FMF) and DADA2. A male patient, currently 29 years old, was initially diagnosed with FMF and developed livedo reticularis and nodular dermal lesions compatible with cutaneous polyarteritis nodosa (PAN) a year after diagnosis. His family history revealed a brother 2 years older than himself who was diagnosed with PAN and died at age 22 because of gut perforation secondary to acute mesenteric ischaemia. ADA2 gene mutation analysis on chromosome 22q11.1 was positive, and the patient responded to colchicine and infliximab.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一例发热发作和血管病变与 ADA2 和 MEFV 致病变体有关的病例。
由腺苷脱氨酶 2(ADA2)基因隐性突变引起的腺苷脱氨酶 2(DADA2)缺乏症会导致皮肤或全身性血管炎,临床表现各异。文献中仅有一例病例同时携带 ADA2 和 MEFV 基因致病变异。在此,我们报告了第二例同时携带 ADA2 和 MEFV 致病变体的病例,该病例同时表现出家族性地中海热(FMF)和 DADA2 的特征性表型。一名现年 29 岁的男性患者最初被诊断为 FMF,并在确诊一年后出现了与皮肤多发性结节炎(PAN)相符的网状组织和结节性真皮病变。他的家族史显示,他的一个哥哥比他大两岁,也被诊断出患有 PAN,并在 22 岁时因急性肠系膜缺血继发肠穿孔而死亡。染色体 22q11.1 上的 ADA2 基因突变分析呈阳性,患者对秋水仙碱和英夫利西单抗有反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Successful peficitinib monotherapy for the new-onset skin manifestations of rheumatoid vasculitis after long-term treatment with tocilizumab for rheumatoid arthritis. Colchicine-responsive chronic recurrent multifocal osteomyelitis associated with familial Mediterranean fever in the presence of MEFV mutation: A case report. Myasthenia gravis with inclusion body myositis: A case report. Secondary fibromyalgia: An entity to be remembered-A case series with axial spondyloarthritis. A case in which baricitinib was effective for both rheumatoid arthritis and essential thrombocythemia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1